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normal in both. Both of them had extracardiac malformation: one had oesoph-
ageal atresia (requiring surgery at day 1), the second had malformation of the
ear and micropenis. Both had neonatal PAH. The first patient received
bosentan at the second month of life. He had persistent PAH (PA pressure of
119/48, mean 77 mm Hg) and underwent closure of a small VSD at the age of
7 months. Two years and half after surgery, he remains in NYHA class II with
similar PA pressure despite bosentan therapy. He is awaiting for combination
therapy with sildenafil. The second presented pulmonary distress at birth
requiring mechanical ventilation. He was placed immediately under a combi-
nation therapy of epoprostenol and NO for 4 days, received then treprostinil
for 15 days and sildenafil. He could be weaned off the ventilator after 3 days.
One month and half after birth, he is doing well under sildenafil but has per-
sistent moderated PAH (tricuspid regurgitation velocity of 3 m/s).
The antenatal existence of high grade arteriovenous shunt could explain
high pulmonary artery pressure. However, the persistence of PAH in these
patients remains unclear. In combination with research of chromosomal
anomaly and congenital malformation, infants with agenesis of the ductus
venosus should benefit after birth of serial ultrasound examination to rule out
PAH. 
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Conotruncal heart defects are among the most frequent congenital heart
diseases. Coronary artery anomalies are commonly associated with outflow
tract malformations. The molecular and cellular mechanisms underlying their
development have yet to be unravelled. TBX1, encoding a T-box transcription
factor, is the major DiGeorge syndrome (del22q11.2) candidate gene and is
required for pharyngeal and cardiovascular development. Tbx1-/- embryos
have severe cardiac anomalies including a common arterial trunk.
DiGeorge syndrome patients have a high incidence of conotruncal defects
including persistant truncus arteriosus and tetralogy of Fallot. We have shown
that the common arterial trunk in Tbx1-/- embryos has an aorta-like phenotype
associated with severe reduction of a subpopulation of second heart field pro-
genitor cells normally contributing to myocardium at the base of pulmonary
trunk. Underdevelopment of subpulmonary myocardium is thought to be the
primary defect in human conotruncal defects like tetralogy of Fallot. Anoma-
lous coronary artery patterning occurs in Tbx1-/- hearts. Semaphorin3c,
encoding a neurovascular guidance molecule is expressed in a Tbx1-dependent
domain in the subpulmonary myocardium. Disruption of the semaphorin sig-
naling pathway during heart morphogenesis results in outflow tract defects and
anomalies of the aortic arch arteries. Sema3c-/- embryos also display common
arterial trunk with interruption of the aortic arch but coronary artery patterning
appears normal.Here we present a comparative analysis of the evolution of
common trunk in these two models and investigate potential genetic interac-
tion between these genes. 
Future subaortic and subpulmonary regions are prefigured in the E10.5 out-
flow tract. Using a candidate gene approach and microarray analysis at E10.5
we aim to identify additional genes expressed in subpulmonary myocardium
that may contribute to conotruncal and coronary artery development.
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Objectives: Senning procedure was performed for the first time in France
at Bordeaux University Hospital in 1965. Follow up have come out focusing
on failing systemic right ventricle and rhythmic complication. The aim of this
work is to identify prognosis factors of reoperation, arrhythmias and right ven-
tricular dysfunction. 
Methods: This single institution study is a retrospective analysis of
132 patients, with simple (105 patients) and complex (27 patients) transposi-
tion of the great arteries, after a Senning procedure between 1977 and 2004.
The mean follow-up time was 19.5 ± 6.6 years.  Conventional follow up and
testing were performed in the same unit. An isotopic ventriculography or MRI
was done for 70 patients to investigate the systemic right ventricular function. 
Results: Operative mortality was 5.3 %. Late mortality was 9.6 %.
9 patients underwent a single reoperation and one needs heart transplantation.
Actuarial survival rate was 91.5 %, 91 %, 89 % and 88 % at respectively 1, 5,
10, and 20 years. There is no statistically difference between simple and com-
plex transposition for actuarial survival rate, maintaining permanent sinus
rhythm or arrhythmias occurrence. After 20 years of 98 % of patients in
simple transposition group have ejection fraction > 40 % versus 58 % in com-
plex transposition (p<0.001). Risk factors of ventricular dysfunction were
complex transposition (p< 0.001) and absence of cardioplegia (p<0.001). Last
follow-up showed 91 % in NYHA class 1. 
Conclusion: Imaging systemic right ventricular dysfunction (FEVD<40%)
was yet uncommon at 20 years of follow-up but is not sufficient to predict a
good response of this ventricle to stress and effort. Long term follow-up after
the Senning operation shows frequent and increasing incidence of sinus node
dysfunction and others arrhythmias: these complications are expected in
double switch procedure.
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Introduction: Coarctation of the aorta (CoA) is a stenosis usually located
in the isthmus of the descending aorta. Treatment consists of surgical or per-
cutaneous removal of the obstruction and may present excellent immediate
results. However, despite immediate good results, significant residual prob-
lems often persist. The aim of the study is to describe the presentation, treat-
ment and long-term evolution of a population of 48 unselected consecutive
patients with CoA in a single pediatric cardiology center. 
Methods: This was a retrospective study of all patients with isolated CoA
associated or not to either atrial or ventricular septal defects. RESULTS: The
patients (n=48, 56,3% male) were diagnosed at a mean age of 84±109 months.
The clinical presentation differed between patients aged less or more than two
years, the former presenting with heart failure and the latter being asymptom-
atic with evidence of hypertension (p < 0.01). Treatment was surgical in all
cases (32 end-to-end anastomosis). The mean age of patients was
94±109 months. There was two late deaths, in a mean follow-up of 8,6±7,7
years. Recoarctation occurred in 12 patients (25%). There are patients who
currently have hypertension (17 at rest, 2 with effort), their mean age at diag-
nosis being older than the others (128 vs. 76 months; p < 0.05). Aortic aneu-
rysms occurred in five patients (10,4 %). Aneurysm was associated to bicuspid
aortic valve in 3 cases. 
Conclusions: repaired CoA has a significant incidence of long-term com-
plications, and should thus no longer be seen as a simple obstruction in the
descending aorta, but rather as a complex pathology that requires careful
follow-up after treatment.
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